WCN24-479 CHARACTERISTICS OF PATIENTS WITH COMPLEMENT 3 GLOMERULOPATHY (C3G) IN A US MULTI-CENTER ASSESSMENT

WCN24-479 CHARACTERISTICS OF PATIENTS WITH COMPLEMENT 3 GLOMERULOPATHY (C3G) IN A US MULTI-CENTER ASSESSMENT

Saved in:

Bibliographic Details
Main Authors:	Briana Ndife, Carolina Aldworth, Kathleen P. Murphy, Jennifer Nguyen, Irina Pivneva, Marie Louise Edwards, Annika Anderson, James Signorovitch, Pietro Canetta
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924005886
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN24-551 CKD PROGRESSION IN PATIENTS WITH COMPLEMENT 3 GLOMERULOPATHY (C3G) IN A US MULTI-CENTER ASSESSMENT
by: Briana Ndife, et al.
Published: (2024-04-01)

WCN24-1436 COLLAPSING LUPUS PODOCYTOPATHY, UNLIKE OTHER COLLAPSING GLOMERULOPATHIES?
by: Elisa Mendoza, et al.
Published: (2024-04-01)

WCN24-104 CLUSTERIN KNOCKOUT MICE: AN EXPERIMENTAL MODEL OF IMMUNOTACTOID GLOMERULOPATHY?
by: XINGLAN LI, et al.
Published: (2024-04-01)

WCN24-105 CLUSTERIN KNOCKOUT MICE: AN EXPERIMENTAL MODEL OF IMMUNOTACTOID GLOMERULOPATHY?
by: XINGLAN LI, et al.
Published: (2024-04-01)

WCN24-1801 A RARE CASE OF COLLAGENOFIBROTIC GLOMERULOPATHY IN A 56 YEAR OLD MALE
by: Simran Sawhney, et al.
Published: (2024-04-01)

WCN24-1839 REAL-WORLD USEFULNESS OF KIDNEY FAILURE RISK EQUATION IN ADULTS WITH BIOPSY-PROVEN GLOMERULOPATHIES
by: Cristina Căpușă, et al.
Published: (2024-04-01)

WCN25-2041 EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH C3 GLOMERULOPATHY: 12-MONTH RESULTS FROM THE PHASE 3 APPEAR-C3G STUDY
by: Carla Nester, et al.
Published: (2025-02-01)

WCN25-1407 INCIDENCE, RISK FACTORS AND OUTCOME OF TRANSPLANT GLOMERULOPATHY
by: EBY MATHEW, et al.
Published: (2025-02-01)

Iptacopan Reduces Proteinuria and Stabilizes Kidney Function in C3 Glomerulopathy
by: Carla M. Nester, et al.
Published: (2025-02-01)

479 Effects of extracellular matrix on pacemaking cardiomyocyte function
by: Brian Howard, et al.
Published: (2025-04-01)

WCN25-4499 Collagenofibrotic glomerulopathy – a rare cause of Nephrotic range proteinuria
by: SRISHTI RATHI, et al.
Published: (2025-02-01)

WCN25-2465 FIBRILLARY GLOMERULONEPHRITIS COEXISTING WITH MEMBRANOUS PATTERN GLOMERULOPATHY : CASE SERIES OF THREE CASES
by: Riti Yadav, et al.
Published: (2025-02-01)

Comparative Analysis of Proteinuria and Longitudinal Outcomes in Immune Complex Membranoproliferative Glomerulonephritis and C3 Glomerulopathy
by: Fernando Caravaca-Fontán, et al.
Published: (2025-04-01)

WCN24-1159 TREATMENT PATTERNS IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY - EVIDENCE FROM REAL-WORLD DATA
by: Serge Smeets, et al.
Published: (2024-04-01)

WCN24-596 COMMUNICATION WORKSHOPS IN NEPHROLOGY THE AUSTRALIAN EXPERIENCE
by: Jenny Chen, et al.
Published: (2024-04-01)

WCN25-1177 PODOCYTE INFOLDING GLOMERULOPATHY IN A SCHOOL-AGED INDIAN CHILD: A NOVEL CASE REPORT
by: Swarnim Swarnim, et al.
Published: (2025-02-01)

Transplant Glomerulopathy: The Interaction of HLA Antibodies and Endothelium
by: William Hanf, et al.
Published: (2014-01-01)

Complement C3c as a Biomarker in Heart Failure
by: A. Frey, et al.
Published: (2013-01-01)

WCN24-1863 Towards an IgA Nephropathy Atlas
by: Julio Saez-Rodriguez, et al.
Published: (2024-04-01)

Fibrillary glomerulopathy:one case report and literature review
by: LV Qian, et al.
Published: (2015-01-01)

WCN24-2174 The role of Ginsenoside Rg3 in Ischemia Reperfusion renal Injury Mice via AMPK and autophagy
by: Kyungho Park, et al.
Published: (2024-04-01)

WCN24-2180 The beneficial effects of ω3-PUFA on renal fibrosis via AMPK-mediated autophagy flux
by: Dae Eun Choi, et al.
Published: (2024-04-01)

WCN24-1358 IL-1β and NLRP3 gene expression profile with dapagliflozin in inactive Lupus Nephritis
by: Gisele Vajgel, et al.
Published: (2024-04-01)

WCN24-622 REVEAL-CKD: EPIDEMIOLOGICAL CHARACTERISTICS OF PATIENTS WITH UNDIAGNOSED STAGE 3 CHRONIC KIDNEY DISEASE IN CHINA
by: Claudia Cabrera, et al.
Published: (2024-04-01)

Clinical characteristics and short term outcomes of childhood immune complex membranoproliferative glomerulonephritis and C3 glomerulopathy: a single centre retrospective study
by: Irshad Ali Bajeer, et al.
Published: (2025-03-01)

WCN24-2118 HYPERKALAEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND HEART FAILURE
by: Simran Parmar, et al.
Published: (2024-04-01)

WCN24-836 IT’S NOT HYDRONEPHROSIS - IT IS PSEUDOHYDRONEPHROSIS!
by: Macaulay Onuigbo, et al.
Published: (2024-04-01)

WCN24-802 ALPORT SYNDROME WITH PODOCYTOPATHY
by: NIHAL BASHIR, et al.
Published: (2024-04-01)

WCN24-412 THE INFLUENCE OF ANGIOPOIETIN-LIKE PROTEIN 3 ON MACROPHAGES POLARIZATION AND ITS EFFECT ON THE PODOCYTE EMT IN DIABETIC NEPHROPATHY
by: Yanli Ma, et al.
Published: (2024-04-01)

A Case of Immunotactoid Glomerulopathy with Rapid Progression to End-Stage Renal Disease
by: Shikha Jain, et al.
Published: (2009-01-01)

WCN24-2081 ATYPICAL MANIFESTATION OF TUBERCULOSIS IN HEMODIALYSIS
by: Veronica Escurra, et al.
Published: (2024-04-01)

WCN24-750 ASSESSMENT OF DRUG INTERACTIONS WITH IPTACOPAN
by: Robert Schmouder, et al.
Published: (2024-04-01)

WCN24-171 DIALYSIS IN NEW OLD PATIENTS
by: Victor Frajewicki, et al.
Published: (2024-04-01)

WCN24-932 THE HISTONE 3 LYSINE 9 METHYLTRANSFERASE INHIBITOR CHAETOCIN IMPROVES KIDNEY FUNCTION IN A MOUSE MODEL OF KIDNEY FIBROSIS
by: CHIA-CHI WU, et al.
Published: (2024-04-01)

Study the Serum Complement C3, C4 and Some Hematology Parameters in COVID-19 Disease
by: Mushtaq Karim Mash Abbas, et al.
Published: (2023-10-01)

The Study of Serum Complement C3, C4 and Immunoglobulin E IgE in Psoriasis Patients
by: Baghdad Science Journal
Published: (2015-12-01)

Comparison of clinical manifestations and prognosis between two pathological types of obesity-related glomerulopathy
by: LU Hai-tao, et al.
Published: (2019-01-01)

Complement C3a promotes the formation of osteoclasts by inhibiting Sirt1 to activate the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma
by: Fengjuan Jiang, et al.
Published: (2025-03-01)

WCN24-1766 EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH MEMBRANOUS NEPHROPATHY
by: Hiddo J.L. Heerspink, et al.
Published: (2024-04-01)

WCN24-1417 HERPES VIRUS EN POSTRASPLANTADO RENAL
by: vanessa emilia oreyano zamora, et al.
Published: (2024-04-01)